A double-blind, multicentre comparison of intravenous dolasetron mesilate and metoclopramide in the prevention of nausea and vomitting in cancer patients receiving high-dose Cisplatin chematherapy

Authors :: Chevallier, B
Cappelaere, P
Splinter, Ted
Fabbro, M
Wendling, JL
Cals, L
Catimel, G
Givanni, M
Khayat, D
Bastit, P
Claverie, N
Chevallier, B
Cappelaere, P
Splinter, Ted
Fabbro, M
Wendling, JL
Cals, L
Catimel, G
Givanni, M
Khayat, D
Bastit, P
Claverie, N
Source :: Chevallier , B , Cappelaere , P , Splinter , T , Fabbro , M , Wendling , JL , Cals , L , Catimel , G , Givanni , M , Khayat , D , Bastit , P & Claverie , N 1997 , ' A double-blind, multicentre comparison of intravenous dolasetron mesilate and metoclopramide in the prevention of nausea and vomitting in cancer patients receiving high-dose Cisplatin chematherapy ' , Supportive Care in Cancer , vol. 5 , pp. 22-30 .
Publication Year :: 1997

Database :: OAIster
Journal :: Chevallier , B , Cappelaere , P , Splinter , T , Fabbro , M , Wendling , JL , Cals , L , Catimel , G , Givanni , M , Khayat , D , Bastit , P & Claverie , N 1997 , ' A double-blind, multicentre comparison of intravenous dolasetron mesilate and metoclopramide in the prevention of nausea and vomitting in cancer patients receiving high-dose Cisplatin chematherapy ' , Supportive Care in Cancer , vol. 5 , pp. 22-30 .
Notes :: application/pdf, und
Publication Type :: Electronic Resource
Accession number :: edsoai.on1313611044
Document Type :: Electronic Resource

Tools